Abstract: Background: The nail involvement in psoriasis is related to psoriatic arthritis and may represent a predictor of the disease. oBjectives: To analyze, through nail clipping, clinically normal and dystrophic nails of patients with cutaneous psoriasis and psoriatic arthritis. Methods: This is a cross-sectional multicenter study, conducted between August 2011 and March 2012. Patients were divided into four groups: patients with cutaneous psoriasis and onychodystrophy, patients with cutaneous psoriasis and clinically normal nails, patients with psoriatic arthritis and onychodystrophy and patients with psoriatic arthritis and clinically normal nails. We calculated NAPSI (Nail Psoriasis Severity Index) of the nail with more clinically noticeable change. After collection and preparation of the nail clipping, the following microscopic parameters were evaluated: thickness of the nail plate and subungual region, presence or absence of parakeratosis, serous lakes, blood, and fungi. results: There were more layers of parakeratosis (p=0.001) and a greater thickness of the subungual region in patients with cutaneous psoriasis and onychodystrophy (p=0.002). Serous lakes were also more present in the same group (p=0.008) and in patients with psoriatic arthritis and normal nails (p=0.047). The other microscopic parameters showed no significant difference between normal and dystrophic nails or between patients with psoriatic arthritis or cutaneous psoriasis. study liMitations: Small sample size and use of medications. conclusions: Nail clipping is a simple and quick method to assess the nails of patients with nail psoriasis although does not demonstrate difference between those with joint changes or exclusively cutaneous psoriasis.
INTRODUCTION
Psoriatic arthritis occurs in 5% to 40% of patients with psoriasis, causing significant morbidity and being responsible for progressive joint destruction. 1,2 Nail dystrophy may be associated with all clinical forms of psoriasis, and may precede or not the cutaneous lesions, preferentially affecting the fingers. 3, 4 However, there seems to be a greater severity of nail involvement in patients with psoriatic arthritis, especially when there is involvement of the distal interphalangeal joint and enthesitis. 1, 5 Nail apparatus of patients with psoriatic arthritis has already been investigated by means of imaging examinations, and histological studies of cadavers have already been performed, but the nails have not previously been studied by the nail clipping method. 6 This method is simple, quick and painless: the nail is cut into its distal and free portion, and the resulting fragment is processed so that it is possible to cut it on the microtome to make a slide for examination under a microscope. The greatest indication of nail clipping is in the diagnostic elucidation of onychomycosis, where the sensitivity of the test can overcome the direct mycological examination and the culture of fungi. [7] [8] [9] Lately, this method has begun to be explored for better investigation of inflammatory nail diseases. 10, 11 In this study, the dystrophic nails of patients with psoriasis were analyzed microscopically, comparing the findings between patients presenting with arthritis and those with cutaneous psoriasis only. NAPSI (Nail Psoriasis Severity Score) was used to compare clinical parameters between the two groups. 12, 13 Clinically normal nails of patients with psoriatic arthritis or exclusively cutaneous psoriasis were used as control groups. At least one fragment of the clinically most dystrophic nail of each patient was harvested, and a greater number of samples were collected for availability. When nails were clinically normal, the nail fragment was collected systematically from the ring finger.
Nail clipping was performed by cutting the distal portion of the free edge of the nail plate with a minimum of 5mm in length and 2mm in width, taking care not to result in discomfort to the patient. 7, 11 The material was stored in sterile vials containing formalin (10% formalin solution). The technical processing of the nails for making the microscopic preparations is described in detail in another publication. 15 The slides were stained with hematoxylin-eosin (HE) and PAS with digestion (PAS-CD were applied. In the existence of statistical significance, the complementary comparisons were performed through the test of Minimum Significant Difference (msd). The level of significance applied to all tests was 0.05.
RESULTS
We evaluated 97 patients. Of these, 41 (42%) had psoriat- ( 
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In Table 2 , all the microscopic variables are exposed comparatively between the groups, in a global way.
DISCUSSION
Nail dystrophy is observed in 40% to 45% of patients with exclusively cutaneous psoriasis and in 87% of patients with psoriatic arthritis. 3, 15, 16 Studies have shown that nail involvement is closely related to psoriatic arthritis and may represent a predictor of the disease. [16] [17] [18] [19] Patients Similarly, the inflammatory reaction mediated by T lymphocytes producing interleukins 12 and 23 has also been proven in patients with exclusively cutaneous disease. [21] [22] [23] However, this model failed to explain the relation between disease involvement in the joints and nail disease, since common nail and joint autoantigens were not identified, as well as the association between interleukins and nail psoriasis and non-psoriatic arthritis is not clearly established. [21] [22] [23] Another theory to try to explain the greater relation between nail psoriasis and psoriatic arthritis is the anatomic connection between the nail structures and the distal interphalangeal joint.
By means of high resolution magnetic resonance imaging, it is possible to identify that the fibers of the extensor tendon of the fingers are anchored directly in the nail matrix and in the periosteum of the distal phalanx, where the nail bed rests. 6 Additionally, collateral ligaments are attached to the lateral edges of the nail, making the nail apparatus an integral part of the musculoskeletal system of the finger. 16, [21] [22] [23] Distal interphalangeal joint enthesitis could trigger the nail structure impairment leading to the onset of nail psoriasis. 17, 22, 23 Although this interpretation is interesting when there is concomitance between nail and finger joints disease, it is of little use for cases of pure cutaneous psoriasis in which dystrophic nails exist even in the absence of arthritis and psoriatic plaques on the hands or feet, for example. A third explanation for onychodystrophy would be based on the fact that the chirodactiles represent frequent areas of trauma through the theory of the Koebner phenomenon. 24 In the present study, NAPSI was applied as a method of clinical evaluation of the degree of nail involvement by the disease. 18 Other studies have demonstrated a greater nail involvement through NAPSI in patients with psoriatic arthritis, with onycholysis being prevalent in the group with joint disease. 5, 24 The methods chosen for evaluation by NAPSI vary among studies, and comparison of results should be conducted very cautiously. According to data from the literature and information obtained with the present study, therefore, it seems pertinent to state that onychodystrophy is more frequent in patients with psoriatic arthritis, but it is not necessarily more severe than that observed in patients with the exclusive cutaneous form. This data should be taken into account when discussing the etiopathogenesis of nail psoriasis, related or not to arthropathy.
Some clinical variables, however, were statistically different between the groups studied. There were significantly more women in the group with psoriatic arthritis and clinically normal nails.
This finding does not have explanations in the literature, which indicates a similar affection in men and women, in both psoriasis and psoriatic arthritis, and may correspond to a selection bias. 25 As for the medications used, as expected, systemic drugs were statistically prevalent in patients with psoriatic arthritis, as well as corticosteroids and sulfasalazine were more commonly used in patients with joint manifestations. 
